YS Biopharma Co Ltd YS

NAS: YS | ISIN: KYG9845F1090 24/05/2024

1,020 USD (+12,45%)

(+12,45%) 24/05/2024

Grafiek YS Biopharma Co Ltd

Grafiek YS Biopharma Co Ltd

1 dag1d 12,45%
1 week1w 0,00%
1 maand1m 0,00%
3 maanden3m 0,00%
6 maanden6m 13,32%
1 jaar1j 75,86%
5 jaar5j -88,00%

YS Biopharma Co Ltd in het nieuws

Toon enkel gratis nieuws

24 mei 2024 · YS Biopharma Announces Name Change to LakeShore Biopharma · Persbericht

21 mei 2024 · YS Biopharma Announces Results of Extraordinary General Meeting · Persbericht

7 mei 2024 · YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer · Persbericht

29 april 2024 · YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule · Persbericht

19 april 2024 · YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 · Persbericht

18 april 2024 · YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine · Persbericht

16 april 2024 · YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024 · Persbericht

9 april 2024 · YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine · Persbericht

3 april 2024 · YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility · Persbericht

5 maart 2024 · YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe